Medical Health Care Advices

Ovarian Cancer  A U.S. clinical study showed that the combination treatment (Avastin) and chemotherapy significantly slows the progression of ovarian cancer. Dr. Robert Burger of Fox Chase Cancer Center in Philadelphia (Pennsylvania East), who led the research, explained that this Phase 3 clinical trial, the first of its kind, has shown that blocking the formation of tumor and blood vessels significantly improves survival without disease progression in women with ovarian cancer or peritoneal very difficult to treat.
“The results of this trial showed that Avastin is an acceptable initial treatment for patients suffering from advanced ovarian cancer,” he said in presenting the results at the annual conference of the American Society of Clinical Oncology (AUC0) meeting this weekend in Chicago (Illinois, North). (more…)

Tumors arising in the ovaries are, in most cases, benign but some are truly malignant, cystic or solid form, originating from cells undergoing malignant transformation and grow in a disorderly and uncontrolled can invade and destroy nearby tissues.

Ovarian cancer causes more deaths than any other type of gynecologic cancer and accounts for 5% of cancer deaths among women. It is estimated that about 2% of women suffer from ovarian cancer at some point in their lives.

There are different types of ovarian tumors, depending on the cell from which they originate. In most cases, approximately 80% are derived from epithelial cells. The rest originates from cells called germ cells or reproductive and serving as a supporting structure of the organ.

(more…)